Acylation of human insulin with palmitic acid extends the time action of human insulin in diabetic dogs

Diabetes

Volumn 46, Issue 4, 1997, Pages 637-642

  Myers, Sharon R ^a   Yakubu Madus, Fatima E ^a   Johnson, William T ^a   Baker, James E ^a   Cusick, Tania S ^a   Williams, Valerie K ^a   Tinsley, Frank C ^a   Kriauciunas, Aidas ^a   Manetta, Joseph ^a   Chen, Victor J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; FATTY ACID; GLUCOSE; HUMAN INSULIN; INSULIN DERIVATIVE; PALMITIC ACID;

ACYLATION; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG SYNTHESIS; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 15144345041     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.4.637     Document Type: Article

References (31)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Galloway JA, Chance RE: Improving insulin therapy: achievements and challenges. Horm Metab Res 26:591-598, 1994
3. Freeman SL, O'Brien PC, Rizza RA Use of human ultralente as the basal insulin component in treatment of patients with IDDM. Diabetes Res Clin Pract 12:187-192, 1991
4. Lauritzen T, Pramming S, Gale EAM, Deckert T, Binder C: Absorption of isophane (NPH) insulin and its clinical implications. Br Med J 285:159-162, 1982
5. Binder C. Absorption of injected insulin. Acta Pharmacol Toxicol 27 (Suppl. 2):1-84, 1969
6. Jørgensen S, Vaag A, Langkjaer L, Hougaard P, Markussen J: NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue. Br Med J 299:415-419, 1989
7. Galloway JA, Hooper S, Spradlin CT, Howey DC, Frank BH, Bowsher RR, Anderson JH: Biosynthetic human proinsulin: review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience. Diabetes Care 15:666-692, 1992
8. Seipke G, Geisen K, Neubauer HP, Pittius C, Roßkamp R, Schwabe D: New insulin preparations with prolonged action profiles: A21 modified arginine insulins. Diabetologia 35 (Suppl. 1):A4, 1992
9. Dreyer M, Pein M, Schmidt Chr, Heidtmann B, Schlünzen M, Roßkamp D: Comparison of the pharmacokinetics/dynamics of Gly(A21)-Arg(B31, B32)-human-insulin (HOE71GT) with NPH-insulin following subcutaneous injection by using euglycaemic clamp technique. Diabetologia 37 (Suppl. 1):A78, 1994
10. Hoffmann JA, Chance RE, Cusick T, Rabe CA, Tinsley FC, Williams VK, Myers SR: Synthesis and bioactivity of des(64,65)-human proinsulin (D) a soluble, intermediate-acting insulin agonist. Diabetes 42 (Suppl. 1):54A, 1993
11. Heinemann L, Heise T, Klepper A, Ampudia J, Bender R, Starke AAR: Time-action profiles of the intermediate-acting insulin analogue des(64,65)-human proinsulin. Diabetes Metab 21:415-419, 1995
12. Cascieri MA, Saperstein R, Hayes NS, Green BG, Chicchi GG, Applebaum J, Bayne ML: Serum half-life and biological activity of mutants of human insulin-like growth factor I which do not bind to serum binding proteins. Endocrinology 123:373-381, 1988
13. Bartalena L: Thyroid hormone transport proteins. Clin Lab Med 13:583-598, 1993
14. Bartalena L: Recent achievements in studies on thyroid-hormone-binding proteins. Endocr Rev 11:47-64, 1990
15. Baumann G, Ambum KD, Buchanan TA: The effect of circulating growth hormone binding protein in metabolic clearance, distribution, and degradation of human growth hormone. J Clin Endocrinol Metab 64:657-660, 1987
16. Van Haeften TW, Bolli GB, Dimitriadis GD, Gottesman IS, Horwitz DL, Gerich JE: Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus. Metabolism 35:649-656, 1986
17. Gray RS, Cowan P, DiMario U, Elton RA, Clarke BF, Duncan LJP: Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics. Br Med J 290:1687-1691, 1985
18. Peters T: Serum albumin. Adv Protein Chem 37:161-245, 1985
19. Doweiko JP, Nompleggi DJ: Role of albumin in human physiology and pathophysiology. J Parenter Enteral Nutr 15:207-211, 1991
20. Carter D, Ho JX: Structure of serum albumin. Adv Protein Chem 45:153-203, 1994
21. Spector AA: Fatty acid binding to plasma albumin. J Lipid Res 16:165-179, 1975
22. Lindsay DG, Shall S: The acetylation of insulin. Biochem J 121:737-745, 1971
23. Lindsay DG, Shall S: Acetoacetylation of insulin. Biochem J 115:587-595, 1969
24. Hashimoto M, Takada K, Kiso Y, Muranishi S: Synthesis of palmitoyl derivatives of insulin and their biological activities. Pharm Res 6:171-176, 1989
25. Markowitz J, Archibald J, Downie HG: Experimental surgery of the pancreas. In Experimental Surgery Including Surgical Physiology. 5th Ed. Baltimore, Williams & Wilkins, 1964, p. 236-252
26. Frank BH, Beckage MJ, Willey KA: High-performance liquid Chromatographic preparation of single-site carrier-free pancreatic polypeptide hormone radiotracers. J Chromatogr 266:239-248, 1983
27. Shoelson SE, Polonsky KS, Zeidler A, Rubenstein AH, Tager HS: Human insulin B24 (phe → ser): secretion and metabolic clearance of the abnormal insulin in man and in a dog model. J Clin Invest 73:1351-1358, 1984
28. 29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
29. Turnheim K, Waldhäusl WK: Essentials of insulin pharmacokinetics. Wien Klin Wochenschr 100:65-72, 1988
30. Kurtzhals P, Havelund S, Jonassen I, Kiehr B, Larsen UD, Ribel U, Markussen J: Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. Biochem J 312:725-731, 1995
31. Markussen J, Havelund S, Kurtzhals P, Andersen AS, Halstrøm J, Hasselager E, Larsen UD, Ribel U, Schäffer L, Vad K, Jonassen I: Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs. Diabetologia 39:281-288, 1996